António Pêgo

417 total citations
7 papers, 357 citations indexed

About

António Pêgo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, António Pêgo has authored 7 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in António Pêgo's work include Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). António Pêgo is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). António Pêgo collaborates with scholars based in Portugal, Belgium and Australia. António Pêgo's co-authors include Andreas Schneeweiß, Angela Zubel, Jutta Groos, Arlene Chan, Salomon M. Stemmer, Miguel Ángel Climent, Helena Melezínková, Ahmad Awada, J. Goeminne and José Baselga and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Neuro-Oncology.

In The Last Decade

António Pêgo

6 papers receiving 352 citations

Peers

António Pêgo

ONCOL

PRM

CR

MB

RNMI

Jutta Groos Germany

Marie-Pascale Graas Belgium

Hobin Yang South Korea

Vidyalakshmi Sethunath United States

Ning Liao China

Amélie Petitprez France

Marion Gilormini France

Alberto Verlicchi Italy

Taniya Saha India

L Ryvo Israel

Jutta Groos Germany

António Pêgo

292 ×1.0

ONCOL

146 ×1.2

PRM

125 ×1.0

CR

101 ×1.1

MB

44 ×1.2

RNMI

Citations per year, relative to António Pêgo António Pêgo (= 1×) peers Jutta Groos

Countries citing papers authored by António Pêgo

Since Specialization

Citations

This map shows the geographic impact of António Pêgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by António Pêgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites António Pêgo more than expected).

Fields of papers citing papers by António Pêgo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by António Pêgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by António Pêgo. The network helps show where António Pêgo may publish in the future.

Co-authorship network of co-authors of António Pêgo

This figure shows the co-authorship network connecting the top 25 collaborators of António Pêgo. A scholar is included among the top collaborators of António Pêgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with António Pêgo. António Pêgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pêgo, António, et al.. (2022). P11.72.A Glioblastoma in elderly patients. Which is the best treatment option?. Neuro-Oncology. 24(Supplement_2). ii75–ii75.

2.

Macedo, Filipa, et al.. (2021). Prognostic factors for early relapse in non-metastatic triple negative breast cancer — real world data. Reports of Practical Oncology & Radiotherapy. 26(4). 563–572. 10 indexed citations

3.

Costa, Cecília Maria Lima da, et al.. (2021). P14.90 Survival outcomes and prognostic factors in glioblastoma patients treated with radiotherapy plus concomitant and adjuvant temozolomide - real-world study. Neuro-Oncology. 23(Supplement_2). ii55–ii55. 1 indexed citations

4.

Baselga, José, Patricia Gómez, Richard Greil, et al.. (2013). Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer. Journal of Clinical Oncology. 31(20). 2586–2592. 298 indexed citations

5.

Baselga, José, Salomon M. Stemmer, António Pêgo, et al.. (2010). Abstract PD01-01: Cetuximab + Cisplatin in Estrogen Receptor-Negative, Progesterone Receptor-Negative, HER2-Negative (Triple-Negative) Metastatic Breast Cancer: Results of the Randomized Phase II BALI-1 Trial. Cancer Research. 70(24_Supplement). PD01–1. 46 indexed citations

6.

Henriques, Isabel, et al.. (2007). Primary chemotherapy with sequential docetaxel followed by docetaxel and epirubicin in large operable breast cancer.. PubMed. 28(6). 447–50. 1 indexed citations

7.

Pêgo, António, et al.. (1999). A carreira já não é o que era .... Open Repository of the University of Porto (University of Porto). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact